The Significant Risk Factors of Intra-Operative Hemorrhage during Laparoscopic Myomectomy: A Systematic Review.

Zaki Sleiman, Rania El Baba, Simone Garzon, Aline Khazaka
Author Information
  1. Zaki Sleiman: Department of Obstetrics and Gynecology, Lebanese American University, Beirut, Lebanon.
  2. Rania El Baba: Laboratory of Science and Research, Saint Joseph University, Beirut, Lebanon.
  3. Simone Garzon: Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy.
  4. Aline Khazaka: Laboratory of Science and Research, Saint Joseph University, Beirut, Lebanon.

Abstract

Laparoscopic myomectomy (LM) is becoming increasingly common in the management of uterine myomas and is usually offered regardless of the number, location, and size of the myomas. It has a generally low rate of periprocedural complications and is preferred to laparotomy for several reasons that are not limited to decreased length of hospital stay, number of sutures, smaller incisions, and decreased pain. However, blood loss during LM remains a challenge. To be able to stratify patients and provide better management after LM, it is crucial to identify these predictors of blood loss. Therefore, the aim of this review was to identify the risk factors for periprocedural blood loss after laparoscopic uterine myomectomy. According to our data synthesis, age, body mass index, and phase of the menstrual cycle do not seem to affect the blood loss during LM. Conversely, size and number of myomas, as well as operative time, was directly related to the increase of blood loss.

Keywords

References

  1. J Obstet Gynaecol Res. 2017 Dec;43(12):1789-1804 [PMID: 28892210]
  2. Arch Gynecol Obstet. 2010 Apr;281(4):645-9 [PMID: 19536553]
  3. JSLS. 2012 Apr-Jun;16(2):276-9 [PMID: 23477178]
  4. J Minim Invasive Gynecol. 2007 Jul-Aug;14(4):453-62 [PMID: 17630163]
  5. Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:43-7 [PMID: 27566221]
  6. Minim Invasive Ther Allied Technol. 2016;25(1):43-7 [PMID: 26329979]
  7. Biomed Res Int. 2016;2016:3617179 [PMID: 27579309]
  8. World J Urol. 2017 Jul;35(7):1155-1156 [PMID: 27757537]
  9. J Minim Invasive Gynecol. 2008 May-Jun;15(3):292-300 [PMID: 18439500]
  10. Int J Surg. 2017 Dec;48:59-63 [PMID: 28951291]
  11. Int J Clin Exp Med. 2014 Mar 15;7(3):764-9 [PMID: 24753775]
  12. Am J Obstet Gynecol. 2013 Oct;209(4):319.e1-319.e20 [PMID: 23891629]
  13. J Minim Invasive Gynecol. 2009 Nov-Dec;16(6):730-3 [PMID: 19896599]
  14. Gynecol Obstet Fertil. 2016 Jun;44(6):350-4 [PMID: 27216952]
  15. Curr Opin Obstet Gynecol. 2015 Dec;27(6):432-7 [PMID: 26485457]
  16. Gynecol Obstet Invest. 2019;84(4):313-325 [PMID: 30554215]
  17. Surg Technol Int. 2006;15:123-9 [PMID: 17029172]
  18. Gynecol Minim Invasive Ther. 2018 Oct-Dec;7(4):161-166 [PMID: 30306035]
  19. Biomed Res Int. 2018 Mar 5;2018:8250952 [PMID: 29693017]
  20. J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):992-6 [PMID: 25958038]
  21. Arch Gynecol Obstet. 2015 Dec;292(6):1185-91 [PMID: 26041328]
  22. Gynecol Minim Invasive Ther. 2017 Oct-Dec;6(4):162-166 [PMID: 30254906]
  23. Wideochir Inne Tech Maloinwazyjne. 2017;12(1):81-87 [PMID: 28446936]
  24. Am J Obstet Gynecol. 2003 Jan;188(1):100-7 [PMID: 12548202]
  25. Obstet Gynecol. 2011 Nov;118(5):1111-25 [PMID: 22015880]
  26. Eur J Obstet Gynecol Reprod Biol. 2009 Jul;145(1):14-21 [PMID: 19398260]
  27. World J Urol. 2015 Dec;33(12):2009-14 [PMID: 25944678]
  28. Arch Gynecol Obstet. 2017 Nov;296(5):855-867 [PMID: 28875276]
  29. J Minim Invasive Gynecol. 2017 Mar - Apr;24(3):466-472 [PMID: 28089810]
  30. Updates Surg. 2016 Dec;68(4):325-329 [PMID: 26801794]
  31. Arch Gynecol Obstet. 2016 Jan;293(1):125-131 [PMID: 26193956]
  32. Minerva Ginecol. 2019 Feb;71(1):18-24 [PMID: 30291702]
  33. Acta Obstet Gynecol Scand. 2017 Dec;96(12):1446-1452 [PMID: 28981986]
  34. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):107-116 [PMID: 29250979]
  35. Aust N Z J Obstet Gynaecol. 2010 Aug;50(4):385-90 [PMID: 20716269]
  36. Gynecol Surg. 2017;14(1):22 [PMID: 29200989]
  37. Fertil Steril. 2001 Feb;75(2):429-33 [PMID: 11172852]
  38. Curr Opin Obstet Gynecol. 2015 Dec;27(6):422-31 [PMID: 26536207]
  39. Biomed Res Int. 2017;2017:6848250 [PMID: 28948169]
  40. Biomed Res Int. 2018 Feb 28;2018:5727165 [PMID: 29675427]
  41. Arch Gynecol Obstet. 2014 Nov;290(5):951-6 [PMID: 24895193]

Word Cloud

Created with Highcharts 10.0.0bloodlossLMmyomectomymyomasnumberLaparoscopicmanagementuterinesizeperiproceduraldecreasedidentifyreviewbecomingincreasinglycommonusuallyofferedregardlesslocationgenerallylowratecomplicationspreferredlaparotomyseveralreasonslimitedlengthhospitalstaysuturessmallerincisionspainHoweverremainschallengeablestratifypatientsprovidebettercrucialpredictorsThereforeaimriskfactorslaparoscopicAccordingdatasynthesisagebodymassindexphasemenstrualcycleseemaffectConverselywelloperativetimedirectlyrelatedincreaseSignificantRiskFactorsIntra-OperativeHemorrhageMyomectomy:SystematicReviewHemoglobindroplaparoscopysystematic

Similar Articles

Cited By